ZNF439
gene geneOn this page
Also known as DKFZp571K0837
Summary
ZNF439 (zinc finger protein 439, HGNC:20873) is a protein-coding gene on chromosome 19p13.2, encoding Zinc finger protein 439 (Q8NDP4). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 90594 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 76 total
- MANE Select transcript:
NM_001348719
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20873 |
| Approved symbol | ZNF439 |
| Name | zinc finger protein 439 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp571K0837 |
| Ensembl gene | ENSG00000171291 |
| Ensembl biotype | protein_coding |
| Entrez | 90594 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 4 protein_coding, 1 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000304030, ENST00000442091, ENST00000455282, ENST00000592495, ENST00000592534, ENST00000682736
RefSeq mRNA: 9 — MANE Select: NM_001348719
NM_001348718, NM_001348719, NM_001348720, NM_001348721, NM_001348722, NM_001348723, NM_001348724, NM_001348725, NM_152262
CCDS: CCDS12268, CCDS86705, CCDS92520
Canonical transcript exons
ENST00000682736 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003525611 | 11866537 | 11866597 |
| ENSE00003918598 | 11866205 | 11866331 |
| ENSE00003921219 | 11848726 | 11848930 |
| ENSE00003921352 | 11867306 | 11869486 |
Expression profiles
Bgee: expression breadth ubiquitous, 199 present calls, max score 85.99.
FANTOM5 (CAGE): breadth broad, TPM avg 4.6393 / max 118.5534, expressed in 910 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 173969 | 4.6393 | 910 |
Top tissues by expression
248 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 85.99 | gold quality |
| ventricular zone | UBERON:0003053 | 85.64 | gold quality |
| ganglionic eminence | UBERON:0004023 | 85.37 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.44 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 82.98 | gold quality |
| cerebellar cortex | UBERON:0002129 | 82.90 | gold quality |
| calcaneal tendon | UBERON:0003701 | 82.21 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 82.13 | gold quality |
| cerebellum | UBERON:0002037 | 81.68 | gold quality |
| adenohypophysis | UBERON:0002196 | 80.50 | gold quality |
| left ovary | UBERON:0002119 | 79.67 | gold quality |
| metanephros cortex | UBERON:0010533 | 79.62 | gold quality |
| granulocyte | CL:0000094 | 79.44 | gold quality |
| right ovary | UBERON:0002118 | 79.44 | gold quality |
| spleen | UBERON:0002106 | 79.31 | gold quality |
| pituitary gland | UBERON:0000007 | 79.12 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 78.48 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 78.47 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 78.34 | gold quality |
| tendon | UBERON:0000043 | 78.03 | gold quality |
| tibial artery | UBERON:0007610 | 77.98 | gold quality |
| popliteal artery | UBERON:0002250 | 77.97 | gold quality |
| thyroid gland | UBERON:0002046 | 77.72 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 77.26 | gold quality |
| ovary | UBERON:0000992 | 77.25 | gold quality |
| right lung | UBERON:0002167 | 77.25 | gold quality |
| right coronary artery | UBERON:0001625 | 77.20 | gold quality |
| adrenal tissue | UBERON:0018303 | 77.18 | gold quality |
| skin of abdomen | UBERON:0001416 | 77.13 | gold quality |
| tibial nerve | UBERON:0001323 | 77.10 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp78 | ENSMUSG00000055150 |
| rattus_norvegicus | ENSRNOG00000083797 | |
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300), ZNF70 (ENSG00000187792)
Protein
Protein identifiers
Zinc finger protein 439 — Q8NDP4 (reviewed: Q8NDP4)
All UniProt accessions (4): A0A0C4DG37, A0A804HI69, C9JMA7, Q8NDP4
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (9): NP_001335647, NP_001335648, NP_001335649, NP_001335650, NP_001335651, NP_001335652, NP_001335653, NP_001335654, NP_689475 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (15 total): zinc finger region 11, sequence variant 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NDP4-F1 | 69.51 | 0.25 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 55 (showing top):
PEREZ_TP63_TARGETS, chr19p13, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, DODD_NASOPHARYNGEAL_CARCINOMA_DN, MARTENS_TRETINOIN_RESPONSE_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CBX7_TARGET_GENES, FOXN3_TARGET_GENES, NFKBIA_TARGET_GENES, MIR6867_5P, MIR4262, MIR6809_3P, MIR181A_5P_MIR181B_5P, MIR181D_5P, MIR181C_5P
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
316 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF439 | OR6S1 | Q8NH40 | 583 |
| ZNF439 | CWF19L2 | Q2TBE0 | 445 |
| ZNF439 | NUDT22 | Q9BRQ3 | 416 |
| ZNF439 | DENND11 | A4D1U4 | 400 |
| ZNF439 | VSTM2B | A6NLU5 | 377 |
| ZNF439 | FAM53A | Q6NSI3 | 374 |
| ZNF439 | RPS7 | P23821 | 357 |
| ZNF439 | DUS3L | Q96G46 | 355 |
| ZNF439 | CTDSPL2 | Q05D32 | 349 |
| ZNF439 | CCDC181 | Q5TID7 | 348 |
| ZNF439 | TMEM205 | Q6UW68 | 348 |
| ZNF439 | BEND4 | Q6ZU67 | 323 |
| ZNF439 | USP54 | Q70EL1 | 308 |
| ZNF439 | HTR3E | A5X5Y0 | 300 |
| ZNF439 | COMMD5 | Q9GZQ3 | 299 |
IntAct
91 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF439 | MDFI | psi-mi:“MI:0915”(physical association) | 0.830 |
| MDFI | ZNF439 | psi-mi:“MI:0915”(physical association) | 0.830 |
| GMNN | ZNF439 | psi-mi:“MI:0915”(physical association) | 0.780 |
| ZNF439 | GMNN | psi-mi:“MI:0915”(physical association) | 0.780 |
| KRTAP5-9 | ZNF439 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF439 | KRTAP10-8 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF439 | KRT40 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP10-8 | ZNF439 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF439 | KRTAP5-9 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT40 | ZNF439 | psi-mi:“MI:0915”(physical association) | 0.720 |
| MTUS2 | ZNF439 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZNF439 | MTUS2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| CCNDBP1 | ZNF439 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-5 | ZNF439 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF439 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (40): ZNF439 (Two-hybrid), ZNF439 (Two-hybrid), ZNF439 (Two-hybrid), ZNF439 (Two-hybrid), ZNF439 (Two-hybrid), ZNF439 (Two-hybrid), KRT40 (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-9 (Two-hybrid), KRTAP10-1 (Two-hybrid), KRTAP10-5 (Two-hybrid), KRTAP10-8 (Two-hybrid), KRTAP10-3 (Two-hybrid), NOTCH2NL (Two-hybrid), ZNF439 (Two-hybrid)
ESM2 similar proteins: A0A1W2PQL4, A0JPL0, A2RRD8, A6NHJ4, A6NP11, B4DX44, O75346, O95780, P0CB33, P21506, P51508, P52738, Q0D2J5, Q0VGE8, Q12901, Q13360, Q14593, Q15973, Q2M218, Q2M3X9, Q2VY69, Q3SXZ3, Q5HY98, Q5RCJ2, Q5VIY5, Q6J6I6, Q7L2R6, Q86XU0, Q86Y25, Q8IW36, Q8IYN0, Q8IYX0, Q8N782, Q8N883, Q8N9Z0, Q8NDP4, Q95K49, Q969W8, Q96H40, Q96N58
Diamond homologs: A0JPK3, A8MT65, C9JN71, E9QAG8, G3X9G7, O75820, P16373, P16374, P16415, P17017, P17024, P17025, P51815, P52737, Q08AG5, Q08ER8, Q0D2J5, Q15973, Q2M218, Q3KP31, Q3V080, Q494X3, Q4R4C7, Q5MYW4, Q5R9F0, Q5R9S5, Q5REI6, Q5REK1, Q68EA5, Q6P560, Q6P5C7, Q6ZQV5, Q7L945, Q86T29, Q8BGV5, Q8C6P8, Q8IYI8, Q8IZC7, Q8N7K0, Q8N972
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 25 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 9 | 29.5× | 2e-10 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
76 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 58 |
| Likely benign | 14 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
105 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:11866329:TAGG:T | donor_loss | 1.0000 |
| 19:11866331:GGTA:G | donor_loss | 1.0000 |
| 19:11866332:GTA:G | donor_loss | 1.0000 |
| 19:11867295:A:AG | acceptor_gain | 1.0000 |
| 19:11867296:T:G | acceptor_gain | 1.0000 |
| 19:11867300:T:TA | acceptor_gain | 1.0000 |
| 19:11867303:CA:C | acceptor_loss | 1.0000 |
| 19:11867304:A:AG | acceptor_gain | 1.0000 |
| 19:11867304:AG:A | acceptor_gain | 1.0000 |
| 19:11867305:G:A | acceptor_loss | 1.0000 |
| 19:11867305:G:GT | acceptor_gain | 1.0000 |
| 19:11867305:GG:G | acceptor_gain | 1.0000 |
| 19:11867305:GGA:G | acceptor_gain | 1.0000 |
| 19:11867305:GGAGT:G | acceptor_gain | 1.0000 |
| 19:11866292:G:T | donor_gain | 0.9900 |
| 19:11866332:G:GG | donor_gain | 0.9900 |
| 19:11866333:T:G | donor_loss | 0.9900 |
| 19:11866532:TTTA:T | acceptor_loss | 0.9900 |
| 19:11866533:TTAGG:T | acceptor_loss | 0.9900 |
| 19:11866534:TAG:T | acceptor_loss | 0.9900 |
| 19:11866535:A:AG | acceptor_gain | 0.9900 |
| 19:11866535:AGG:A | acceptor_loss | 0.9900 |
| 19:11866536:G:GC | acceptor_loss | 0.9900 |
| 19:11866536:G:GG | acceptor_gain | 0.9900 |
| 19:11866593:TTCAG:T | donor_loss | 0.9900 |
| 19:11866594:TCAG:T | donor_loss | 0.9900 |
| 19:11866595:CAGG:C | donor_loss | 0.9900 |
| 19:11866596:AGGTA:A | donor_loss | 0.9900 |
| 19:11866597:GGTAA:G | donor_loss | 0.9900 |
| 19:11866598:GT:G | donor_loss | 0.9900 |
AlphaMissense
3376 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:11868240:T:C | F391L | 0.987 |
| 19:11868242:C:A | F391L | 0.987 |
| 19:11868242:C:G | F391L | 0.987 |
| 19:11868408:T:C | F447L | 0.985 |
| 19:11868410:C:A | F447L | 0.985 |
| 19:11868410:C:G | F447L | 0.985 |
| 19:11868156:T:C | F363L | 0.982 |
| 19:11868158:T:A | F363L | 0.982 |
| 19:11868158:T:G | F363L | 0.982 |
| 19:11868324:T:C | F419L | 0.979 |
| 19:11868326:C:A | F419L | 0.979 |
| 19:11868326:C:G | F419L | 0.979 |
| 19:11867820:T:C | F251L | 0.976 |
| 19:11867822:T:A | F251L | 0.976 |
| 19:11867822:T:G | F251L | 0.976 |
| 19:11868492:T:C | F475L | 0.974 |
| 19:11868494:C:A | F475L | 0.974 |
| 19:11868494:C:G | F475L | 0.974 |
| 19:11867904:T:C | F279L | 0.971 |
| 19:11867906:C:A | F279L | 0.971 |
| 19:11867906:C:G | F279L | 0.971 |
| 19:11868330:T:C | S421P | 0.969 |
| 19:11868414:T:C | S449P | 0.967 |
| 19:11868241:T:C | F391S | 0.958 |
| 19:11866238:T:C | F28L | 0.955 |
| 19:11866240:C:A | F28L | 0.955 |
| 19:11866240:C:G | F28L | 0.955 |
| 19:11868281:C:A | H404Q | 0.955 |
| 19:11868281:C:G | H404Q | 0.955 |
| 19:11867736:T:C | F223L | 0.953 |
dbSNP variants (sampled 300 via entrez): RS1000075737 (19:11860587 A>C), RS1000086154 (19:11864541 C>G), RS1000186843 (19:11849077 G>T), RS1000554986 (19:11847607 G>A), RS1001017853 (19:11849776 T>A), RS1001069775 (19:11849509 C>G,T), RS1001291508 (19:11869624 CT>C,CTT,CTTTTT), RS1001297620 (19:11854721 G>A), RS1001629376 (19:11857664 G>T), RS1001731737 (19:11851920 T>A), RS1001805399 (19:11852143 G>A), RS1001903943 (19:11855976 C>T), RS1001922850 (19:11854114 C>T), RS1002010841 (19:11847350 C>T), RS1002065448 (19:11850664 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST011358_11 | Academic attainment (English) | 3.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0011015 | educational attainment |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, decreases expression, affects cotreatment | 3 |
| trichostatin A | affects cotreatment, decreases expression | 2 |
| bisphenol S | affects cotreatment, decreases methylation, increases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| belinostat | increases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| licochalcone B | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Hydralazine | increases expression, affects cotreatment | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Lipopolysaccharides | decreases expression, affects response to substance, increases expression | 1 |
| Plant Extracts | increases expression, affects cotreatment | 1 |
| Quercetin | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.